Influenza Vaccine Production News
Most Popular Influenza Vaccine Production Story
Novartis, HHS unveil pandemic-ready vax plant
A joint effort by government and industry has begotten a nearly $1 billion cell-culture flu vaccine manufacturing facility. Novartis ($NVS) and the U.S. Department of Health and Human Services Read more...
Latest Headlines
- January 3, 2012
- December 14, 2011
- August 23, 2011
- February 24, 2011
- August 24, 2010
- November 10, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
